Urinary Tract Drops
Generic Name: urinary tract drops
Brand Names:
Urinary Tract Drops 2122
*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Overview
*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Uses
INDICATIONS For the temporary relief of urinary discomfort or difficulty, frequent urination, or mild abdominal or back pain.*
Dosage
DIRECTIONS Place drops under tongue 30 minutes before/after meals. Adults and children 12 years and over: Take 10 drops up to 3 times per day. Consult a physician for use in children under 12 years of age.
Warnings
WARNINGS Consult a doctor if condition worsens, if symptoms persist, or are accompanied by a fever or bloody or cloudy urine. Keep out of the reach of children. In case of overdose, get medical help or contact a poison control center right away. If pregnant or breastfeeding, ask a healthcare professional before use. Keep out of the reach of children. If pregnant or breastfeeding, ask a healthcare professional before use.
Pregnancy
If pregnant or breastfeeding, ask a healthcare professional before use.
Frequently Asked Questions
What is Urinary Tract Drops used for?▼
INDICATIONS For the temporary relief of urinary discomfort or difficulty, frequent urination, or mild abdominal or back pain.*
Can I take Urinary Tract Drops during pregnancy?▼
If pregnant or breastfeeding, ask a healthcare professional before use.
What are the important warnings for Urinary Tract Drops?▼
WARNINGS Consult a doctor if condition worsens, if symptoms persist, or are accompanied by a fever or bloody or cloudy urine. Keep out of the reach of children. In case of overdose, get medical help or contact a poison control center right away. If pregnant or breastfeeding, ask a healthcare professional before use. Keep out of the reach of children. If pregnant or breastfeeding, ask a healthcare professional before use.
Related Medications
Ranibizumab-nuna
ranibizumab-nuna
Vascular Endothelial Growth Factor Inhibitor [EPC]
11 DESCRIPTION BYOOVIZ (ranibizumab-nuna) is a recombinant humanized IgG1 kappa isotype monoclonal antibody fragment designed for intraocular use. Ranibizumab-nuna binds to and inhibits the biologic activity of human vascular endothelial growth factor A (VEGF-A). Ranibizumab-nuna, which lacks an Fc region, has a molecular weight of approximately 48 kilodaltons and is produced by an E. coli expression system in a nutrient medium containing the antibiotic tetracycline.
Octocrylene, Octinoxate, Avobenzone, Oxybenzone
octocrylene, octinoxate, avobenzone, oxybenzone
Purpose: Sunscreen
Pantoprazole Sodium Delayed-release
pantoprazole sodium delayed-release
11 DESCRIPTION The active ingredient in pantoprazole sodium delayed-release tablets, a PPI, is a substituted benzimidazole, sodium 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl] sulfinyl]-1 H -benzimidazole sesquihydrate, a compound that inhibits gastric acid secretion. Its empirical formula is C 16 H 14 F 2 N 3 NaO 4 S x 1.5 H 2 O, with a molecular weight of 432.37. The structural formula is: Pantoprazole sodium is a white to off-white powder and is racemic.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.